Insomnia in Long COVID Syndrome

Prevalence and Characteristics

Insomnia is a significant component of long COVID syndrome, affecting approximately 22% of patients with persistent symptoms beyond 12 weeks after COVID-19 infection 1
Sleep disturbances, particularly insomnia, are among the commonly reported symptoms in long COVID, with prevalence rates ranging from 11% to 44% across different studies 1

Insomnia in long COVID often co-exists with other neurological and cognitive symptoms, including fatigue, cognitive impairment, memory loss, and sensorimotor symptoms 2
Sleep disturbances are part of the broader neurological manifestations of long COVID, which affect the quality of life and daily functioning of patients 1
Cognitive impairment, which is found in patients with COVID-19, often occurs alongside sleep disturbances, creating a complex symptom pattern 2

Neuroinflammation and immune dysregulation affecting brain regions involved in sleep regulation may contribute to insomnia in long COVID 2
Activation of the kynurenine pathway, with metabolites associated with cognitive and sleep disturbances, is a proposed mechanism for insomnia in long COVID 2
Possible viral persistence in tissues, including neurological structures, may also play a role in the development of insomnia in long COVID 3
Autonomic nervous system dysfunction affecting sleep-wake cycles is another potential mechanism underlying insomnia in long COVID 4

Insomnia symptoms can persist for months to years after the initial COVID-19 infection 1
Sleep disturbances and cognitive symptoms can persist for at least 2 years, according to a longitudinal analysis 2